| NCT ID | NCT05526105 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dartmouth-Hitchcock Medical Center |
| Condition | Critical Illness |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-02-03 |
| Primary Completion | 2025-02-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2023-02-03 with a primary completion date of 2025-02-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a case series study using gastric ultrasound in critically ill patients to quantify gastric residual volumes to compare the efficacy of different NPO protocols.
Eligibility Criteria
Inclusion Criteria: * Patients age 18 or older, admitted to the ICU, requiring general anesthesia or sedation for a procedure with a pre-existing, cuffed endotracheal or tracheostomy tube. Most patients admitted to the ICU would be unable to consent. Exclusion Criteria: * Known upper gastrointestinal anatomical problem that would prevent accurate estimation of gastric volume, gastric perforation, pregnancy beyond the first trimester. * Lack of a pre-existing, cuffed endotracheal or tracheostomy tube.
Contact & Investigator
Laura M Chiang, MD
PRINCIPAL INVESTIGATOR
Dartmouth-Hitchcock Medical Center
Frequently Asked Questions
Who can join the NCT05526105 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Critical Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05526105 currently recruiting?
Yes, NCT05526105 is actively recruiting participants. Contact the research team at laura.m.chiang@hitchcock.org for enrollment information.
Where is the NCT05526105 trial being conducted?
This trial is being conducted at Lebanon, United States.
Who is sponsoring the NCT05526105 clinical trial?
NCT05526105 is sponsored by Dartmouth-Hitchcock Medical Center. The principal investigator is Laura M Chiang, MD at Dartmouth-Hitchcock Medical Center. The trial plans to enroll 50 participants.